The first recorded proof of a bird not seen for 140 years, a gut bacteria that could regulate cholesterol and a senior who risked his own life to rescue a man from an oncoming subway train were among the most-read Cornell Chronicle stories of 2022.
The new, collaborative Precision Behavioral Health Initiative aims to use both smart devices and artificial intelligence to help individuals, and their doctors, monitor and manage behavioral health.
Xiaolong Liu, a postdoctoral researcher in physics, and Wen Zhang, a postdoctoral researcher in chemistry, both in the College of Arts and Sciences, have received 2022 Blavatnik Regional Awards for Young Scientists.
The 2023 VCNG Continuation of Service Award was presented to Jennifer Ross, an Executive MBA Metro NY candidate in the Samuel Curtis Johnson Graduate School of Management at the Cornell SC Johnson College of Business.
In patients with severe artery blockage in the lower leg, an artery-supporting device called a resorbable scaffold is superior to angioplasty, according to the results of a large international clinical trial co-led by researchers at Weill Cornell Medicine and NewYork-Presbyterian.
More than 70 faculty from Weill Cornell Medicine, Cornell Engineering and Cornell Tech assembled Oct. 1 at the Statler Ballroom — and more joined remotely — to kick off the Cornell Engineering Innovations in Medicine initiative.
Researchers at Weill Cornell Medicine have developed a pre-clinical model of the leading cause of central vision loss in older individuals, dry age-related macular degeneration, and used it to identify new treatment modalities and drug targets.
The Samuel Curtis Johnson Graduate School of Management unveiled the diverse group of 25 startups that make up the 2023 Johnson Summer Startup Accelerator (JSSA), the program's largest cohort to date.
Adult vaccination rates and social determinants of health – the social and economic conditions in which families live and work – have played an important role in children’s mental health during the pandemic, according to a new study led by Weill Cornell Medicine investigators.
Afghan visual artist Elja Sharifi, currently a visiting scholar at the Herbert F. Johnson Museum of Art, sees her escape from the Taliban as a call to action. She will enter Cornell’s PhD program in art history next fall.